Specimen SS-F-M2-07591 // MULTI-AXIS · IFI-M
SB Sequential Integration Series III-PR-A
Stevia rebaudiana
Stevia
Target Trait
2.4×
fold-change
Sweet+Bitter-Attenuation sequential pathway fold-change
Technical Specifications
SKU
SS-F-M2-07591
Genomic Edits
8
GC Content
46.2%
Construct Length
4,380 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
TAS1R2/TAS1R3 + TAS2R38 (suppression)
IFI Score
240
Pathway Edits
- TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
- TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
- Bidirectional promoter system for synchronized S+B dual-axis co-expression
- Metabolic flux partitioning between IFI-S and IFI-B pathway branches via carbon flow optimization
- Transcription factor co-binding site engineering for Sweet-Bitter-Attenuation combinatorial gene regulation
- Cross-pathway feedback inhibition circuit removal for S+B simultaneous accumulation
- Cofactor balance optimization for S+B dual-pathway operation
- Protein scaffold engineering for S+B enzyme co-localization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Tier III SB dual-axis sequential integration platform for food ingredient applications requiring verified combined sweet+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.
License
$1499 · Tier III License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?